Your search results

Human retroviruses are mainly associated with cancer development and immunological conditions.
Early diagnosis and treatment of both HIV and HTLV are a major challenge for clinicians worldwide.
The diagnostic solution for retroviruses enables early viral detection and supports the clinical management of the patient.

Viral hepatitis infection is associated with significant morbidity and mortality.
Accurate and early diagnosis reduces the risk of transmission and supports effective patient management.
The complete solution for a reliable differentiation among five viral hepatitis infections, including Hepatitis Delta and E detection.

The first high-throughput, fully automated CLIA assay to quickly differentiate between bacterial and viral infections in a single procedure. Combining host-immune protein measurements it overcomes the diagnostic difficulties of traditional testing methods, making LIAISON^® MeMed BV^® ideal for patients with suspected acute infections.

LIAISON^® QuantiFERON TB-Gold Plus is an IGRA based-test that drastically improves tuberculosis testing compared to traditional tests.

The first complete solution with optimal diagnostic performance for Bordetella pertussis diagnosis 

• LIAISON^® Bordetella pertussis Toxin IgA
• LIAISON^® Bordetella pertussis Toxin IgG

Differential serological diagnosis of Mycoplasma Pneumoniae: a crucial step for effective patient management.

The first high-quality quantitative CLIA assay that assesses disease severity in patients with a suspected infection by detecting Mid-regional pro-adrenomedullin (MR-proADM^TM) via a single test. It is ideal for patients with suspected acute infections at ED and ICU.

Viral hepatitis infection is associated with significant morbidity and mortality.
Accurate and early diagnosis reduces the risk of transmission and supports effective patient management.
The complete solution for a reliable differentiation among five viral hepatitis infections, including Hepatitis Delta and E detection.

Human retroviruses are mainly associated with cancer development and immunological conditions.
Early diagnosis and treatment of both HIV and HTLV are a major challenge for clinicians worldwide.
The diagnostic solution for retroviruses enables early viral detection and supports the clinical management of the patient.

Differential serological diagnosis of Mycoplasma Pneumoniae: a crucial step for effective patient management.

LIAISON^® QuantiFERON TB-Gold Plus is an IGRA based-test that drastically improves tuberculosis testing compared to traditional tests.

Automated CLIA assay for the qualitative determination of antibodies to Treponema pallidum in human serum and plasma samples including specimens collected post-mortem.

Total automation for accurate differential diagnosis of the measles virus

Total automation for accurate differential diagnosis of the mumps virus.

Total automation for accurate differential diagnosis of the varicella zoster virus.

Fully automated solution for the diagnosis of fertility affecting conditions and hormonal monitoring.

Total automation for accurate differential diagnosis of Parvovirus B19.

Total automation for the accurate staging of CMV infection.

Human retroviruses are mainly associated with cancer development and immunological conditions.
Early diagnosis and treatment of both HIV and HTLV are a major challenge for clinicians worldwide.
The diagnostic solution for retroviruses enables early viral detection and supports the clinical management of the patient.

The LIAISON^® Lyme Disease Diagnostic Solution panel ensures improved diagnostic accuracy in detecting Lyme borreliosis infection. It includes LIAISON® LymeDetect®, a new paradigm for early stage detection, and the serologic IgG and IgM LIAISON^® Borrelia tests.

Total automation for accurate differential diagnosis of the measles virus

Total automation for accurate differential diagnosis of the mumps virus.

Total automation for accurate differential diagnosis of the varicella zoster virus.

Fully automated solution for the diagnosis of fertility affecting conditions and hormonal monitoring.

Total automation for accurate differential diagnosis of Parvovirus B19.

Fully automated solution for the diagnosis of fertility affecting conditions and hormonal monitoring.

Total automation for accurate differential diagnosis of Parvovirus B19.

Total automation for the accurate staging of CMV infection.

Total automation for accurate differential diagnosis of the Herpes Simplex Virus.

Total automation for accurate differential diagnosis of the Rubella virus.

Total automation for the accurate staging of infection

Fully automated solution for the diagnosis of fertility affecting conditions and hormonal monitoring.

Total automation for accurate differential diagnosis of Parvovirus B19.

Total automation for the accurate staging of CMV infection.

Total automation for accurate differential diagnosis of the Herpes Simplex Virus.

Total automation for accurate differential diagnosis of the Rubella virus.

Total automation for the accurate staging of infection

The first high-throughput, fully automated CLIA assay to quickly differentiate between bacterial and viral infections in a single procedure. Combining host-immune protein measurements it overcomes the diagnostic difficulties of traditional testing methods, making LIAISON^® MeMed BV^® ideal for patients with suspected acute infections.

LIAISON^® QuantiFERON TB-Gold Plus is an IGRA based-test that drastically improves tuberculosis testing compared to traditional tests.

The first complete solution with optimal diagnostic performance for Bordetella pertussis diagnosis 

• LIAISON^® Bordetella pertussis Toxin IgA
• LIAISON^® Bordetella pertussis Toxin IgG

Fully automated solution for the diagnosis of fertility affecting conditions and hormonal monitoring.

Total automation for the accurate staging of CMV infection.

Total automation for accurate differential diagnosis of the Herpes Simplex Virus.

Total automation for accurate differential diagnosis of the Rubella virus.

Total automation for the accurate staging of infection

Human retroviruses are mainly associated with cancer development and immunological conditions.
Early diagnosis and treatment of both HIV and HTLV are a major challenge for clinicians worldwide.
The diagnostic solution for retroviruses enables early viral detection and supports the clinical management of the patient.

Automated CLIA assay for the qualitative determination of antibodies to Tripanosoma cruzi in human serum and plasma samples including specimens collected post-mortem.

Automated CLIA assay for the qualitative determination of antibodies to Treponema pallidum in human serum and plasma samples including specimens collected post-mortem.

Viral hepatitis infection is associated with significant morbidity and mortality.
Accurate and early diagnosis reduces the risk of transmission and supports effective patient management.
The complete solution for a reliable differentiation among five viral hepatitis infections, including Hepatitis Delta and E detection.

Automated CLIA assay for the qualitative determination of antibodies to Tripanosoma cruzi in human serum and plasma samples including specimens collected post-mortem.

Automated CLIA assay for the qualitative determination of antibodies to Treponema pallidum in human serum and plasma samples including specimens collected post-mortem.

The first high-throughput, fully automated CLIA assay to quickly differentiate between bacterial and viral infections in a single procedure. Combining host-immune protein measurements it overcomes the diagnostic difficulties of traditional testing methods, making LIAISON^® MeMed BV^® ideal for patients with suspected acute infections.

LIAISON^® QuantiFERON TB-Gold Plus is an IGRA based-test that drastically improves tuberculosis testing compared to traditional tests.

The first complete solution with optimal diagnostic performance for Bordetella pertussis diagnosis 

• LIAISON^® Bordetella pertussis Toxin IgA
• LIAISON^® Bordetella pertussis Toxin IgG

Differential serological diagnosis of Mycoplasma Pneumoniae: a crucial step for effective patient management.

The first high-quality quantitative CLIA assay that assesses disease severity in patients with a suspected infection by detecting Mid-regional pro-adrenomedullin (MR-proADM^TM) via a single test. It is ideal for patients with suspected acute infections at ED and ICU.

LIAISON^® BRAHMS PCT^® II Gen is a CLIA assay for the quantitative determination of procalcitonin in human serum and plasma specimens. The assay is intended for use, in conjunction with other laboratory findings and clinical assessments, to aid in the risk analysis for critically ill patients regarding the progression of relevant bacterial infections.

The first high-quality quantitative CLIA assay that assesses disease severity in patients with a suspected infection by detecting Mid-regional pro-adrenomedullin (MR-proADM^TM) via a single test. It is ideal for patients with suspected acute infections at ED and ICU.

LIAISON^® BRAHMS PCT^® II Gen is a CLIA assay for the quantitative determination of procalcitonin in human serum and plasma specimens. The assay is intended for use, in conjunction with other laboratory findings and clinical assessments, to aid in the risk analysis for critically ill patients regarding the progression of relevant bacterial infections.

The first high-throughput, fully automated CLIA assay to quickly differentiate between bacterial and viral infections in a single procedure. Combining host-immune protein measurements it overcomes the diagnostic difficulties of traditional testing methods, making LIAISON^® MeMed BV^® ideal for patients with suspected acute infections.

LIAISON^® QuantiFERON TB-Gold Plus is an IGRA based-test that drastically improves tuberculosis testing compared to traditional tests.

The first complete solution with optimal diagnostic performance for Bordetella pertussis diagnosis 

• LIAISON^® Bordetella pertussis Toxin IgA
• LIAISON^® Bordetella pertussis Toxin IgG

Differential serological diagnosis of Mycoplasma Pneumoniae: a crucial step for effective patient management.

Total automation for accurate differential diagnosis of the measles virus

Total automation for accurate differential diagnosis of the mumps virus.

Total automation for accurate differential diagnosis of the varicella zoster virus.

Fully automated solution for the diagnosis of fertility affecting conditions and hormonal monitoring.

Total automation for accurate differential diagnosis of Parvovirus B19.

Total automation for accurate differential diagnosis of the measles virus

Total automation for accurate differential diagnosis of the mumps virus.

Total automation for accurate differential diagnosis of the varicella zoster virus.

Fully automated solution for the diagnosis of fertility affecting conditions and hormonal monitoring.

Total automation for accurate differential diagnosis of Parvovirus B19.

Fully automated solution for the diagnosis of fertility affecting conditions and hormonal monitoring.

Total automation for the accurate staging of CMV infection.

Total automation for accurate differential diagnosis of the Herpes Simplex Virus.

Total automation for accurate differential diagnosis of Parvovirus B19.

Total automation for accurate differential diagnosis of the Rubella virus.

Total automation for the accurate staging of infection